↓ Skip to main content

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

Overview of attention for article published in Arthritis Research & Therapy, December 2011
Altmetric Badge

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
Published in
Arthritis Research & Therapy, December 2011
DOI 10.1186/ar3537
Pubmed ID
Authors

Patricia Guyot, Peter Taylor, Robin Christensen, Louisa Pericleous, Coralie Poncet, Maximilian Lebmeier, Pieter Drost, Gert Bergman

Abstract

The goal of this study was to compare the efficacy in terms of Health Assessment Questionnaire change from baseline (HAQ CFB), 50% improvement in American College of Rheumatology criterion (ACR-50) and Disease Activity Score in 28 joints (DAS28) defined remission (< 2.6) between abatacept and other biologic disease modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) who have inadequate response to methotrexate (MTX-IR).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 2%
Colombia 1 1%
Unknown 80 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 20%
Student > Master 14 17%
Student > Ph. D. Student 9 11%
Other 7 8%
Student > Doctoral Student 6 7%
Other 19 23%
Unknown 11 13%
Readers by discipline Count As %
Medicine and Dentistry 42 51%
Agricultural and Biological Sciences 6 7%
Social Sciences 4 5%
Immunology and Microbiology 4 5%
Nursing and Health Professions 3 4%
Other 11 13%
Unknown 13 16%